Mycoplasma genitalium
Device
Gen-Probe, Inc.
Total Payments
$81,333
Transactions
15
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $81,333 | 15 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $81,333 | 15 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Mycoplasma genitalium prevalence project | Gen-Probe, Inc. | $30,009 | 0 |
| Use the Hologic test to evaluate the prevalence of Mycoplasma genitalium | Gen-Probe, Inc. | $23,740 | 0 |
| Mycoplasma genitalium surveillance project | Gen-Probe, Inc. | $20,584 | 0 |
| Mycoplasma genitalium prevalence in Rhode Island | Gen-Probe, Inc. | $7,000 | 0 |
Top Doctors Receiving Payments for Mycoplasma genitalium
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Winter Park, CO | $81,333 | 15 |
Ad
Manufacturing Companies
- Gen-Probe, Inc. $81,333
Product Information
- Type Device
- Total Payments $81,333
- Total Doctors 0
- Transactions 15
About Mycoplasma genitalium
Mycoplasma genitalium is a device associated with $81,333 in payments to 0 healthcare providers, recorded across 15 transactions in the CMS Open Payments database. The primary manufacturer is Gen-Probe, Inc..
Payment data is available from 2019 to 2019. In 2019, $81,333 was paid across 15 transactions to 0 doctors.
The most common payment nature for Mycoplasma genitalium is "Unspecified" ($81,333, 100.0% of total).
Mycoplasma genitalium is associated with 4 research studies, including "Mycoplasma genitalium prevalence project" ($30,009).